Moreover, cisplatin can sensitize tumor cells to granzyme B by augmenting tumor cell permeability and by increasing the expression of the granzyme-target caspase-3, which mediates the execution phase of apoptosis (76, 77). Here, CASP3 is linked to neoplasm.